PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18600585-0	2008	AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders.	davunetide	0-6	catenin beta like 1	Homo sapiens	55-58	
21524250-0	2011	NAP (davunetide) provides functional and structural neuroprotection.	davunetide	5-15	catenin beta like 1	Homo sapiens	0-3	
21524250-1	2011	NAP (davunetide) is an eight amino acid peptide (NAPVSIPQ) that has been shown to provide potent neuroprotection, in vitro and in vivo.	davunetide	5-15	catenin beta like 1	Homo sapiens	0-3	
21524250-1	2011	NAP (davunetide) is an eight amino acid peptide (NAPVSIPQ) that has been shown to provide potent neuroprotection, in vitro and in vivo.	davunetide	49-57	catenin beta like 1	Homo sapiens	0-3	
18600585-0	2008	AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders.	davunetide	11-17	catenin beta like 1	Homo sapiens	55-58	
18600585-1	2008	Allon Therapeutics Inc is developing AL-108, an intranasally administered, eight-amino-acid peptide fragment (known as NAP) of activity-dependent neuroprotective protein, and AL-208, an intravenous formulation of NAP.	davunetide	37-43	catenin beta like 1	Homo sapiens	119-122	
24120997-5	2014	In this work we provide new evidence that an agent that promotes microtubule network assembly, NAP (davunetide), improves microtubule-dependent traffic, restores the autophagic flux and potentiates autophagosome-lysosome fusion leading to autophagic vacuole clearance in Parkinson"s disease cells.	davunetide	100-110	catenin beta like 1	Homo sapiens	95-98	
30865715-0	2019	NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.	davunetide	5-15	catenin beta like 1	Homo sapiens	0-3	
30865715-7	2019	Clinically, NAP (davunetide, CP201) exhibited efficacy in prodromal Alzheimer"s disease patients (Tau3R/4R tauopathy) but not in progressive supranuclear palsy (increased Tau4R tauopathy).	davunetide	17-27	catenin beta like 1	Homo sapiens	12-15	
16888216-1	2006	NAP is an eight-amino acid neuroprotective peptide NAPVSIPQ; it is the smallest active element derived from the recently cloned activity-dependent neuroprotective protein (ADNP).	davunetide	51-59	catenin beta like 1	Homo sapiens	0-3	
24533805-1	2014	This review focuses on the therapeutic effects and mechanisms of action of NAP (davunetide), an eight amino acid snippet derived from activity-dependent neuroprotective protein (ADNP) which was discovered in the laboratory of Prof. Illana Gozes.	davunetide	80-90	catenin beta like 1	Homo sapiens	75-78